233 related articles for article (PubMed ID: 24737780)
1. Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3.
Komiya E; Sato H; Watanabe N; Ise M; Higashi S; Miyagi Y; Miyazaki K
Cancer Med; 2014 Jun; 3(3):537-49. PubMed ID: 24737780
[TBL] [Abstract][Full Text] [Related]
2. Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis.
Hooper AT; Shmelkov SV; Gupta S; Milde T; Bambino K; Gillen K; Goetz M; Chavala S; Baljevic M; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; Vahdat L; Evans T; Rafii S
Circ Res; 2009 Jul; 105(2):201-8. PubMed ID: 19542015
[TBL] [Abstract][Full Text] [Related]
3. Angiomodulin (IGFBP7) is a cerebral specific angiocrine factor, but is probably not a blood-brain barrier inducer.
Bar O; Gelb S; Atamny K; Anzi S; Ben-Zvi A
Fluids Barriers CNS; 2020 Apr; 17(1):27. PubMed ID: 32238174
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of angiomodulin (AGM/IGFBP-rP1) in tumor stroma and its roles in fibroblast activation.
Komiya E; Furuya M; Watanabe N; Miyagi Y; Higashi S; Miyazaki K
Cancer Sci; 2012 Apr; 103(4):691-9. PubMed ID: 22321149
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
[TBL] [Abstract][Full Text] [Related]
6. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
7. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin.
Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS
Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3.
Zhong L; Tang L; He X
Bioengineered; 2022 Feb; 13(2):2971-2980. PubMed ID: 35038961
[TBL] [Abstract][Full Text] [Related]
9. Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?
Bekes I; Friedl TW; Köhler T; Möbus V; Janni W; Wöckel A; Wulff C
Mol Cancer; 2016 Feb; 15():13. PubMed ID: 26868378
[TBL] [Abstract][Full Text] [Related]
10. Brag2 differentially regulates β1- and β3-integrin-dependent adhesion in endothelial cells and is involved in developmental and pathological angiogenesis.
Manavski Y; Carmona G; Bennewitz K; Tang Z; Zhang F; Sakurai A; Zeiher AM; Gutkind JS; Li X; Kroll J; Dimmeler S; Chavakis E
Basic Res Cardiol; 2014 Mar; 109(2):404. PubMed ID: 24522833
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells.
Usui T; Murai T; Tanaka T; Yamaguchi K; Nagakubo D; Lee CM; Kiyomi M; Tamura S; Matsuzawa Y; Miyasaka M
Int Immunol; 2002 Nov; 14(11):1273-82. PubMed ID: 12407018
[TBL] [Abstract][Full Text] [Related]
12. IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis.
Zhang C; Lu L; Li Y; Wang X; Zhou J; Liu Y; Fu P; Gallicchio MA; Bach LA; Duan C
Int J Cancer; 2012 May; 130(9):2003-12. PubMed ID: 21618524
[TBL] [Abstract][Full Text] [Related]
13. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis.
Medina J; Caveda L; Sanz-Cameno P; Arroyo AG; Martín-Vílchez S; Majano PL; García-Buey L; Sánchez-Madrid F; Moreno-Otero R
J Hepatol; 2003 May; 38(5):660-7. PubMed ID: 12713878
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma.
Oh SH; Kim WY; Lee OH; Kang JH; Woo JK; Kim JH; Glisson B; Lee HY
Cancer Sci; 2012 Jul; 103(7):1259-66. PubMed ID: 22494072
[TBL] [Abstract][Full Text] [Related]
16. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
17. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.
Peddibhotla SS; Brinkmann BF; Kummer D; Tuncay H; Nakayama M; Adams RH; Gerke V; Ebnet K
Mol Biol Cell; 2013 Apr; 24(7):933-44. PubMed ID: 23389628
[TBL] [Abstract][Full Text] [Related]
18. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
Ray A; Alalem M; Ray BK
J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer.
Chung MJ; Jung SH; Lee BJ; Kang MJ; Lee DG
Pathol Int; 2004 Jan; 54(1):10-5. PubMed ID: 14674989
[TBL] [Abstract][Full Text] [Related]
20. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.
Alghisi GC; Ponsonnet L; Rüegg C
PLoS One; 2009; 4(2):e4449. PubMed ID: 19212436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
